Similar Papers

Paper Title
Journal
Date
Author
Effect of docetaxel combined cisplatin for treatment of non small - cell lung cancer
-
25 Sep 2008
Chemotherapy and Survival in Non-Small Cell Lung Cancer: The Old Vexata Questio
Gianfranco Buccheri
Chest | VOL. 99
Gianfranco BuccheriGianfranco Buccheri
01 Jun 1991
PACIFIC: Time for a surgical IIIA uprising
Harvey I Pass
The Journal of Thoracic and Cardiovascular Surgery | VOL. 156
Harvey I PassHarvey I Pass
04 Jun 2018
Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report
B Coudert ... P Fumoleau
European Journal of Cancer | VOL. 37
B Coudert, et. al.B Coudert ... P Fumoleau
01 Jan 2001
View more papers

More From: Lung Cancer

Paper Title
Journal
Date
Author
Evaluating tumour budding could improve the new grading system for lung adenocarcinoma
Kirsi K Volmonen ... Aija H Knuuttila
Lung Cancer | VOL. 199
Kirsi K Volmonen, et. al.Kirsi K Volmonen ... Aija H Knuuttila
01 Jan 2025
Sunvozertinib monotherapy in EGFR tyrosine kinase Inhibitor-Resistant Non-Small cell lung cancer with EGFR mutations
Mengzhao Wang ... James Chih-Hsin Yang
Lung Cancer | VOL. 199
Mengzhao Wang, et. al.Mengzhao Wang ... James Chih-Hsin Yang
01 Jan 2025
Efficacy of immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma and predictive potential of mutated TP53
Mingying Wu ... Yuzhou Wang
Lung Cancer | VOL. 199
Mingying Wu, et. al.Mingying Wu ... Yuzhou Wang
01 Jan 2025
Adherence to community-based lung cancer screening in the Yorkshire Lung Screening Trial
Sarah Q Ahmad ... Matthew E.J Callister
Lung Cancer | VOL. -
Sarah Q Ahmad, et. al.Sarah Q Ahmad ... Matthew E.J Callister
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.